Cargando…
CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma
Recent studies have described a number of genes that are frequently altered in medulloblastoma tumors and that have putative key roles in the development of the disease. We hypothesized that common germline genetic variations in these genes may be associated with medulloblastoma development. Based o...
Autores principales: | Dahlin, Anna M., Hollegaard, Mads V., Wibom, Carl, Andersson, Ulrika, Hougaard, David M., Deltour, Isabelle, Hjalmars, Ulf, Melin, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592490/ https://www.ncbi.nlm.nih.gov/pubmed/26290144 http://dx.doi.org/10.1007/s11060-015-1891-1 |
Ejemplares similares
-
Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma
por: Ghasimi, Soma, et al.
Publicado: (2016) -
A genome-wide association study on medulloblastoma
por: Dahlin, Anna M., et al.
Publicado: (2020) -
Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification
por: Wang, Chan, et al.
Publicado: (2019) -
PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer
por: Ozcan, Gulnihal
Publicado: (2023) -
SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance
por: Cruickshank, V. Adam, et al.
Publicado: (2015)